Electrophysiology Market by Product, by Indication - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • ID: 3773625
  • Report
  • Region: Global
  • 120 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • General Electric Co.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medtronic plc
  • MORE
Electrophysiology Market by Product (EP Ablation Catheters, EP Laboratory Devices, EP Diagnostic Catheters, Access Devices), Indication (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia, Wolff-Parkinson-White Syndrome) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

Electrophysiology (EP) is the branch of science that deals with the study of electric activity in the human body. EP devices are used to treat abnormal electrical properties of cell and tissues that leads to various cardiac arrhythmias. Innovative EP technologies are developed to improve the diagnosis and treatment of life-threatening conditions, such as atrial fibrillation (AF), atrial flutter, Wolff-Parkinson-White Syndrome (WPW), atrioventricular nodal reentry tachycardia (AVNRT), and other cardiac arrhythmias.

The growing incidence of AF-one of the most common heart rhythm disorder or arrhythmia is the prime factor to drive the growth of the EP market. In addition, cardiovascular diseases treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications. Increase in baby boomer generation with high-risk of targeted diseases and increase in adoption of EP catheter ablation propels the market growth. Moreover, rise in focus of the key players toward innovative EP technologies (such as 3D mapping systems, novel diagnostic catheters, and laser ablation systems), has fuel the demand for EP devices across various settings in EP labs. However, stringent government regulations, high cost of the advanced EP devices, preference to pharmaceutical interventions (drugs) over EP treatment devices and dearth of skilled & experienced electrophysiologists are set to restrain the market growth. The world electrophysiology market is projected reach $8,271 Million by 2022, growing at a CAGR of 13.4% during 2016 to 2022, from 2015 market value of $3,420 million.

The world electrophysiology market is segmented on the basis of product, indication and geography. Based on product, the market is segmented primarily into EP ablation catheters, EP laboratory devices, EP diagnostic catheters, access devices and others. EP ablation catheter is further sub-segmented into cryoablation EP catheters, radiofrequency EP catheters, microwave EP catheters, laser EP catheters, and navigational advanced mapping accessories. Radiofrequency EP catheters are further categorized into conventional and irrigated-tip ablation catheters. Radiofrequency EP catheters has the largest market share, owing to high prevalence rate of atrial fibrillation and technological advancements in RF ablation such as irrigated tip catheters, which is found to be superior (in terms of efficacy and safety) than conventional RF ablation. Cryoablation EP catheter market is expected to grow at the fastest rate due to technological advancements in this sector and preferred option by the physicians to ablate abnormal cardiac cells, where procedural precision is crucial. In addition, EP X-Ray Systems holds remarkable share in the EP market and poised to grow at steady pace due to the growing demand in EP labs to enhance the ability to perform complex procedures with confidence. Moreover, steerable diagnostic catheters are the driving force behind the growth of conventional EP diagnostic catheters attributed to the rising adoption of these devices gaining FDA approval for the treatment of AF. Based on indication, the market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), Wolff-Parkinson-white syndrome (WPW) and others. Atrial fibrillation holds the highest share in the indication segment owing to the high incident rate and the most common type of cardiac arrhythmia in clinical practice.

The geographical segmentation of the market includes North America, Europe, Asia-Pacific, and LAMEA. In 2015, North America accounted for the largest market share of 36.2% in the EP market and estimated to retain its dominant position throughout the forecast period. The growth in this region is mainly due to the factors such as product innovations, sophisticated healthcare infrastructure, U.S. – being the target area for the top players in the market owing to high prevalence rate of AF. Nevertheless, Asia Pacific region is expected to emerge as the area with maximum growth potential due to the rising number of cardiovascular diseases, presence of high unmet needs, and increased focus of key players towards emerging markets such as China and India, and increased healthcare spending for the development of improved healthcare infrastructure.

Product development and launch is the mostly adopted strategy in the electrophysiology market followed by acquisition. The report provides a comprehensive analysis of the key players that operate in the world Electrophysiology market such as:

St. Jude Medical, Inc.
Boston Scientific Corporation,
Biosense Webster, Inc. (a Johnson & Johnson Company)
Medtronic, Inc.
Siemens AG
GE Healthcare (a division of General Electric Company.)
Philips Healthcare (a division of Koninklijke Philips N.V.)
Biotronik SE & Co.KG
Abbott Laboratories.
Microport Scientific Corporation

KEY MARKET BENEFITS

The study provides an in-depth analysis of the world electrophysiology market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of the market, by product, helps understand various types of devices used for the treatment of atrial fibrillation, atrial flutter, Wolff-Parkinson-White Syndrome, atrioventricular nodal reentry tachycardia, and other cardiac arrhythmias.
Competitive intelligence highlights the business practices followed by the leading market players across various geographies.
Porter’s Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.

Key market segments

By Product

EP Ablation Catheters
Cryoablation EP Catheters
Radiofrequency Ablation Catheters
Irrigated-tip Radiofrequency Ablation Catheters
Conventional Radiofrequency Ablation Catheters
Microwave Ablation Systems
Laser Ablation Systems
Navigational Advanced Mapping Accessories
EP Laboratory Devices
EP X-Ray Systems
3D Mapping Systems
EP Recording Systems
EP Remote Steering Systems
Others
EP Diagnostic Catheters
Conventional EP Diagnostic Catheters
Steerable Diagnostic Catheters
Fixed Diagnostic Catheters
Advanced EP Diagnostic Catheters
Ultrasound EP Diagnostic Catheters
Access Devices
Others
By Indication

Atrial Fibrillation (AF)
Atrial Flutter
Wolff-Parkinson-White Syndrome (WPW)
Atrioventricular Nodal Reentry Tachycardia (AVNRT)
Others

BY GEOGRAPHY

North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
Egypt
Israel
South Africa
Rest of LAMEA
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • General Electric Co.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medtronic plc
  • MORE
CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key market benefits
1.3 Key market segments:
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Bargaining power of suppliers
3.3.2 Bargaining power of buyers
3.3.3 Threats of new entrants
3.3.4 Threats of substitutes
3.3.5 High intensity of rivalry

3.4 Market share analysis, 2015
3.5 Market dynamics

3.5.1 Drivers

3.5.1.1 Technological advancements in EP Devices
3.5.1.2 Growing incidence of AF due to increasing baby booming generation
3.5.1.3 Unmet medical needs with upcoming treartment modifictions
3.5.1.4 Increasing preference of EP catheter ablation for cardiac arrhythmia treatment

3.5.2 Restraints

3.5.2.1 High cost of the EP Device
3.5.2.2 Dearth of skilled electrophysiologists
3.5.2.3 Preference to pharmaceutical interventions (drugs) over EP treatment devices

3.5.3 Opportunities

3.5.3.1 Lucrative opportunities in emerging economies
3.5.3.2 Rising awareness regarding the EP technologies

CHAPTER 4 WORLD ELECTROPHYSIOLOGY MARKET, BY PRODUCT, 2014-2022, ($MILLION)

4.1 Overview

4.1.1 Market size and forecast

4.2 EP ablation catheters

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Cryoablation EP catheters

4.2.4.1 Market size and forecast

4.2.5 Radiofrequency (RF) ablation catheters

4.2.5.1 Market size and forecast
4.2.5.2 Conventional RF ablation catheters

4.2.5.2.1 MARKET SIZE AND FORECAST

4.2.5.3 Irrigated-tip RF ablation catheters

4.2.5.3.1 MARKET SIZE AND FORECAST

4.2.6 Microwave ablation (MWA) systems

4.2.6.1 Market size and forecast

4.2.7 Laser ablation systems

4.2.7.1 Market size and forecast

4.2.8 Navigational advanced mapping accessories

4.2.8.1 Market size and forecast

4.3 EP laboratory devices

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 3D mapping systems

4.3.4.1 Market size and forecast

4.3.5 EP recording systems

4.3.5.1 Market size and forecast

4.3.6 EP X-Ray systems

4.3.6.1 Market size and forecast

4.3.7 EP remote steering systems

4.3.7.1 Market size and forecast

4.3.8 Others

4.3.8.1 Market size and forecast

4.4 Electrophysiology diagnostic catheters

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast
4.4.4 Conventional EP diagnostic catheters

4.4.4.1 Market size and forecast
4.4.4.2 Fixed diagnostic catheters

4.4.4.2.1 MARKET SIZE AND FORECAST

4.4.4.3 Steerable diagnostic catheters

4.4.4.3.1 MARKET SIZE AND FORECAST

4.4.5 Advanced EP diagnostic catheters

4.4.5.1 Market size and forecast

4.4.6 Ultrasound EP diagnostic catheters

4.4.6.1 Market size and forecast

4.5 Access devices

4.5.1 Key market trends
4.5.2 Key growth factors and opportunities
4.5.3 Market size and forecast

4.6 Others

4.6.1 Key market trends
4.6.2 Key growth factors and opportunities
4.6.3 Market size and forecast

CHAPTER 5 WORLD ELECTROPHYSIOLOGY MARKET, BY INDICATION, 2014-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 Atrial Fibrillation

5.2.1 Market size and forecast

5.3 Atrial Flutter

5.3.1 Market size and forecast

5.4 Atrioventricular Nodal Reentrant Tachycardia (AVNRT)

5.4.1 Market size and forecast

5.5 Wolff-Parkinson-White Syndrome (WPW)

5.5.1 Market size and forecast

5.6 Others

5.6.1 Market size and forecast

CHAPTER 6 WORLD ELECTROPHYSIOLOGY MARKET, BY GEOGRAPHY, 2014-2022

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast

6.2.3.1 U.S. Market size and forecast
6.2.3.2 Canada Market size and forecast
6.2.3.3 Mexico Market size and forecast

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast

6.3.3.1 Germany Market size and forecast
6.3.3.2 France Market size and forecast
6.3.3.3 U.K. Market size and forecast
6.3.3.4 Italy Market size and forecast
6.3.3.5 Rest of Europe Market size and forecast

6.4 Asia-Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast

6.4.3.1 India Market size and forecast
6.4.3.2 China Market size and forecast
6.4.3.3 Japan Market size and forecast
6.4.3.4 Australia Market size and forecast
6.4.3.5 Rest of Asia-Pacific Market size and forecast

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast

6.5.3.1 Brazil Market size and forecast
6.5.3.2 Argentina Market size and forecast
6.5.3.3 Egypt Market size and forecast
6.5.3.4 IsraelMarket size and forecast
6.5.3.5 South Africa Market size and forecast
6.5.3.6 Rest of LAMEA Market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1 Abbott Laboratories

7.1.1 Company overview
7.1.2 Company snapshot
7.1.3 Operating business segments
7.1.4 Business performance
7.1.5 Key strategic moves and developments

7.2 Johnson & Johnson

7.2.1 Company overview
7.2.2 Company snapshot
7.2.3 Operating business segments
7.2.4 Business performance
7.2.5 Key strategic moves and developments

7.3 Microport Scientific Corporation

7.3.1 Company overview
7.3.2 Company snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key strategic moves and developments

7.4 Boston Scientific Corporation

7.4.1 Company overview
7.4.2 Operating business segments
7.4.3 Business performance
7.4.4 Key strategic moves and developments

7.5 St. Jude Medical, Inc.

7.5.1 Company overview
7.5.2 Company snapshot
7.5.3 Operating business segments
7.5.4 Business performance
7.5.5 Key strategic moves and developments

7.6 Medtronic plc

7.6.1 Company overview
7.6.2 Company snapshot
7.6.3 Operating business segments
7.6.4 Business performance
7.6.5 Key strategic moves and developments

7.7 Biotronik SE & Co. KG

7.7.1 Company overview
7.7.2 Company snapshot
7.7.3 Operating business segments
7.7.4 Key strategic moves and developments

7.8 Koninklijke Philips N.V.

7.8.1 Company overview
7.8.2 Company snapshot
7.8.3 Operating business segments
7.8.4 Business performance
7.8.5 Key strategic moves and developments

7.9 General Electric Co.

7.9.1 Company overview
7.9.2 Company snapshot
7.9.3 Operating business segments overview
7.9.4 Business performance
7.9.5 Key strategic moves and developments

7.10 Siemens AG

7.10.1 Company overview
7.10.2 Company snapshot
7.10.3 Operating business segments
7.10.4 Financial performance
7.10.5 Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik SE & Co. KG
  • General Electric Co.
  • Johnson & Johnson
  • Koninklijke Philips N.V.
  • Medtronic plc
  • MORE
A new report titled, "Electrophysiology Market - Global Opportunity Analysis and Industry Forecast, 2014 - 2022", states that the global electrophysiology market was $3,420 million in 2015 and is expected to reach $8,271 million by 2022, growing at a CAGR of 13.4% from 2016 to 2022. Electrophysiology (EP) ablation catheters is expected to dominate the global electrophysiology market throughout the forecast period. North America accounted more than one-third share of the global electrophysiology market in 2015.

The market is driven by growth in incidence of atrial fibrillation (one of the most common heart rhythm disorder or cardiac arrhythmia), growth in baby boomer generation with high-risk of targeted diseases, and increase in adoption of EP catheter ablation. Rise in focus of the key players toward innovative EP technologies (such as 3D mapping systems, bidirectional duodecapolar diagnostic catheter, remote steering systems, and irrigated-tip RF catheters), and growth in EP labs further drives the market growth. However, stringent government regulations, high cost of the treatment of complex arrhythmias, preference to pharmaceutical interventions (drugs) over, and dearth of skilled & experienced electrophysiologists restrain the market growth.

EP ablation catheters (such as cryoablation EP catheters, radiofrequency ablation catheters, microwave ablation systems, laser ablation systems and navigational advanced mapping accessories) was a leading segment and accounted for more than 35.0% of total share in 2015. Ablation catheters is preferred due to its diversified use in the treatment of cardiac arrhythmias with lower risk and high success rate. Cryoablation EP catheters market is expected to grow at the fastest CAGR of 15.1%, owing to benefits such as less thrombogenic effects compared to RF ablation catheters, high success rate, and faster recovery. Advanced EP diagnostics catheters market is expected to grow at a CAGR of 14.2%, due to technological advancements in the segment.

Atrial fibrillation (AF) indication segment is expected to maintain its lead in the overall electrophysiology market due to its high incidence rate, especially in the developed economies. Although, the AF cases are prevalent in the developing economies, the low awareness, less initiative for preventive care, and unmet medical needs at economical cost has restricted the market growth. Conversely, the growing demand of electrophysiology devices in the developed economies such as North America and Europe has further boosted the market growth due to the high incidence rate of AF, rapidly increasing ageing population, and growing number of EP labs. Furthermore, atrioventricular nodal reentry tachycardia (AVNRT) indication is anticipated to exhibit the highest growth, with a CAGR of 14.8%. The aforementioned is due to the most common regular supraventricular arrhythmia in humans. Nevertheless, despite the smaller target market, it is expected that the cryoablation procedures performed for the treatment of AVNRT will increase at a moderate rate attributable to the physicians adoption of the product and an increase in the number of AVNRT procedures worldwide.

Key Findings of the Electrophysiology Market

In 2015, EP ablation catheter was the leading product type, and is projected to grow at a high CAGR of 14.4%.
Cryoablation EP catheters is expected to grow at a remarkable CAGR of 15.1%.
Irrigated-tip RF ablation catheters is projected to grow at a high CAGR of 14.6%.
U.S. was the highest market shareholder with over 80% in the North American region in 2015.
Japan is the major shareholder, accounting for around half of the Asia-Pacific electrophysiology market.
North America is expected to dominate the EP market followed Europe, during the analysis period.
North America accounted for the major share in 2015, and is expected to maintain this trend throughout the forecast period. This is due to the rise in prevalence of cardiac arrhythmias coupled with increase in geriatric population, high adoption rate of technologically advanced electrophysiology devices, and high awareness regarding the benefits of electrophysiology devices. In addition, presence of highly sophisticated healthcare infrastructure, rising interventional procedures for the treatment of cardiac arrhythmias especially atrial fibrillation, and favorable reimbursement scenario has propelled the market growth. However, Asia-Pacific region is anticipated to grow rapidly attributed to the presence of ample growth opportunities in terms of unmet medical needs for the treatment of cardiac arrhythmias in this region and quest for improved quality of life in emerging countries.

Some of the key companies profiled in the report are St. Jude Medical, Inc., Biosense Webster, Inc. (A Johnson & Johnson Company), Boston Scientific Corporation, Medtronic, Inc., GE Healthcare (Division of General Electric Co.), Siemens AG, Medtronic plc, Philips Healthcare (A Division of Koninklijke Philips N.V.), Biotronik SE & Co.KG, Microport Scientific Corporation, and Abbott Laboratories.
Note: Product cover images may vary from those shown
5 of 5
- Abbott Laboratories
- Johnson & Johnson
- Microport Scientific Corporation
- Boston Scientific Corporation
- St. Jude Medical
- Medtronic plc
- Biotronik SE & Co. KG
- Koninklijke Philips N.V.
- General Electric Co.
- Siemens AG
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll